Chih-Wei received his BSc in Biotechnology and MSc in Applied Chemistry from National Chiao Tung University in 2018.
He was working at the Institute of Atomic and Molecular Sciences, Academia Sinica, with Dr. Jung-Chi Liao. Subsequently, he joined Syncell Inc., a startup company expertized in spatially proteomic profiling and biomarker discovery.
Chih-Wei joined the Bayley and the Qing group in 2022. His research interest focuses on nanopore characterization of protein isoforms. Chih-Wei is funded by the Ministry of Education, Taiwan(ROC).